← SynDRA
SELETALISIB
SynDRA canonical compound SYN0039737 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | PIK3CD |
|---|
| Mechanism of action | PI3K inhibitor |
|---|
All known targets
- PIK3CD
- PIK3CA
- PIK3CB
- PIK3CG
Mechanisms of action (all sources)
- PIK3CD INHIBITOR
- PI3-kinase p110-delta subunit inhibitor
- PIK3CA INHIBITOR
- PIK3CB INHIBITOR
- PIK3CG INHIBITOR
- PI3K inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- KSYK
- NSD2
- PK3CA
- PK3CB
- PK3CG
- SYK
Cross-references
Synonyms
- UCB5857
- UCB-5857
- UCB 5857
- seletalisibum
- RefChem:182320
- Seletalisib (UCB-5857)
- Seletalisib [INN]
- SELETALISIB [WHO-DD]
- GTPL9800
- orb1296248
- SCHEMBL15363617
- SCHEMBL29369672
- LNLJHGXOFYUARS-OAQYLSRUSA-N
- BDBM50512879
- EX-A11525
- CS-6470
- NCGC00509999-01
- HY-16754
- MS-28982
- NS00073427
- G14569
- MEC85020
Look up SELETALISIB in the interactive SynDRA portal →